4//SEC Filing
Trenschel Robert J. 4
Accession 0001493152-23-021133
CIK 0001357459other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:44 PM ET
Size
8.5 KB
Accession
0001493152-23-021133
Insider Transaction Report
Form 4
Trenschel Robert J.
Director
Transactions
- Award
Restricted Stock Units
2023-06-11+5,100→ 5,100 total→ Common Stock (5,100 underlying) - Award
Common Stock Options
2023-06-11+12,160→ 12,160 totalExercise: $1.60Exp: 2033-06-11→ Common Stock (12,160 underlying)
Footnotes (5)
- [F1]Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.
- [F2]The grants vest fully on the one (1) year anniversary of the grant date.
- [F3]Each restricted stock unit represents the right to receive one share of common stock.
- [F4]N/A
- [F5]Each option represents the right to purchase one share of common stock at the exercise price.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001849917
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:44 PM ET
- Size
- 8.5 KB